Acetazolamide: future perspective in topical glaucoma therapeutics.
about
Management of Root Resorption Using Chemical Agents: A ReviewOcular drug delivery.Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride.Dorzolamide chlorhydrate versus acetazolamide in the management of chronic macular edema in patients with retinitis pigmentosa: description of three case reports.Acetazolamide attenuates chemical-stimulated but not thermal-stimulated acute pain in mice.Ocular delivery of macromoleculesPharmacotherapy of glaucoma.Expansion of first-in-class drug candidates that sequester toxic all-trans-retinal and prevent light-induced retinal degeneration.Knock-down of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosisBrinzolamide.Ocular preservatives: associated risks and newer options.Stable overexpression of DNA fragmentation factor in T-47D cells: sensitization of breast cancer cells to apoptosis in response to acetazolamide and sulfabenzamide.Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension.Promising complexes of acetazolamide for topical ocular administration.Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.Free-solution interaction assay of carbonic anhydrase to its inhibitors using back-scattering interferometry.The Role of pH Regulation in Cancer Progression.Acetazolamide potentiates the afferent drive to prefrontal cortex in vivo.Acetazolamide triggers death inducing autophagy in T-47D breast cancer cells.Identification of a nuclear carbonic anhydrase in Caenorhabditis elegans.Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery.Novel sulphamides and sulphonamides incorporating the tetralin scaffold as carbonic anhydrase and acetylcholine esterase inhibitors.Synthesis and carbonic anhydrase isoenzymes I and II inhibitory effects of novel benzylamine derivatives.Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.Syntheses of Novel 4-Substituted N-(5-amino-1H-1,2,4-triazol-3-yl)pyridine-3-sulfonamide Derivatives with Potential Antifungal Activity.Synthesis, Characterization and Antibacterial Studies of N-(Benzothiazol-2-yl)-4-chlorobenzenesulphonamide and Its Neodymium(III) and Thallium(III) Complexes.Investigation of the inhibitory properties of some phenolic standards and bee products against human carbonic anhydrase I and II.A DFT-Based QSARs Study of Acetazolamide/Sulfanilamide Derivatives with Carbonic Anhydrase (CA-II) Isozyme Inhibitory Activity.Influence of acetazolamide loading on the (in vitro) performances of non-phospholipid-based cationic nanosized emulsion in comparison with phospholipid-based anionic and neutral-charged nanosized emulsions.How Diverse Are the Protein-Bound Conformations of Small-Molecule Drugs and Cofactors?GCDB: a glaucomatous chemogenomics database for in silico drug discoveryStructural and Vibrational Study on Monomer and Dimer Forms and Water Clusters of Acetazolamide
P2860
Q26769589-0C076EFD-F7E2-4F72-BDE2-2432BE6FAE99Q30475605-8B4C1D66-B4A7-4CC2-8754-6B492414D7DDQ33573405-BB531DEB-A15E-4E6C-B0F1-FEEDA5900EBAQ33734786-663D20AD-1D7C-45EE-87D4-96C1655376F2Q33823701-4B68AE67-F4A5-438B-BAE8-42666AC46AD3Q34079676-B3E7D049-7305-43B9-9A12-206D8137721DQ35138049-37D2A2C5-F33E-44BC-BB72-CE6CD4447991Q35156386-A63BE8D6-AD27-408C-AA93-284752A88FFDQ36516789-E6AB6A7D-B64F-4C62-AE9E-806946872B7FQ37099034-67627D54-419E-48C3-AFED-743D52AC116BQ37510923-0E0131AA-E1D0-466A-8A99-A473CD3B5A0CQ37554712-D6D645A7-CC72-4DCC-9DEC-4DA0F630C365Q37577462-0C801536-BF17-4F80-BF78-35F7EAAD0CEAQ37766607-83B6C252-AB3C-4164-B4C7-59C22418A77DQ38239017-E7244148-9B62-4010-89DB-FD338BAA0E11Q38926288-830A83F7-2D83-45A5-9ADD-2CC1B4D6F9B8Q38936259-8519653A-7326-49A7-A2D6-40AFCA947E5EQ39020916-7DB6E293-D239-4231-87B6-7D6690DB0F9CQ39071997-167AE608-DC50-4B06-8197-2E2AA91FDD5BQ42160367-923A0B66-E21E-48A7-9508-B299660952C7Q43025578-C620BA80-AD2B-47A4-B6A0-E237B850339DQ43784513-83DCE3E4-9912-4877-9054-EE28DE63D3F8Q44015636-7125C5E1-5AB5-4B70-B528-1D8E8CFB9D6FQ44908210-791668A1-CFAC-4690-83FB-ED04F76D3B38Q45162709-6221E9F4-3E32-459D-ACFD-82EF4BEEDD7EQ46266827-17BBC3BE-DE1E-4BFA-B437-56DE7310B626Q46267325-FB436B05-F12C-4C90-8F92-589F3203303DQ46497215-C14DA017-FB80-4C99-8685-5F1DEDFB483BQ46731654-959CDA70-D381-4771-8D08-DBFC1405874BQ51589973-41A42921-8A1D-4B44-A3DF-9DC4BE6A111DQ54327473-BC3E03AB-87FC-4456-87A3-31B277606CC2Q58132502-E02A7D42-D7B9-42CD-93E2-AFCA971BA6F1Q59020949-EB2E30F1-88CA-491D-9316-933408CB50DC
P2860
Acetazolamide: future perspective in topical glaucoma therapeutics.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Acetazolamide: future perspective in topical glaucoma therapeutics.
@ast
Acetazolamide: future perspective in topical glaucoma therapeutics.
@en
Acetazolamide: future perspective in topical glaucoma therapeutics.
@nl
type
label
Acetazolamide: future perspective in topical glaucoma therapeutics.
@ast
Acetazolamide: future perspective in topical glaucoma therapeutics.
@en
Acetazolamide: future perspective in topical glaucoma therapeutics.
@nl
prefLabel
Acetazolamide: future perspective in topical glaucoma therapeutics.
@ast
Acetazolamide: future perspective in topical glaucoma therapeutics.
@en
Acetazolamide: future perspective in topical glaucoma therapeutics.
@nl
P2093
P1476
Acetazolamide: future perspective in topical glaucoma therapeutics.
@en
P2093
Deepika Aggarwal
Indu Pal Kaur
Mona Kapil
P356
10.1016/S0378-5173(02)00438-6
P407
P577
2002-11-01T00:00:00Z